Kodiak Sciences Inc.
DE ˙ DB ˙ US50015M1099
€ 28,86 ↑3.72 (14.80%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:K27 / Kodiak Sciences Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership3,273,386 shares
Ownership 5.30%
BlackRock, Inc. ownership in K27 / Kodiak Sciences Inc.

2026-04-27 - BlackRock, Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,273,386 shares of Kodiak Sciences Inc. (DE:K27). This represents 5.3 percent ownership of the company. In their previous filing dated 2025-04-29 , BlackRock, Inc. had reported owning 2,301,991 shares, indicating an increase of 42.20 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-04-27 2026-04-27 13G 2,301,991 3,273,386 42.20 5.30 20.45
2025-04-29 2025-04-29 13G/A 4,032,822 2,301,991 -42.92 4.40 -42.86
2024-01-26 2024-01-26 13G/A 4,287,809 4,032,822 -5.95 7.70 -6.10
2023-02-03 2023-02-03 13G 2,553,534 4,287,809 67.92 8.20 67.35
2022-03-09 2022-03-09 13G/A 2,851,198 2,553,534 -10.44 4.90 -10.91
2022-02-03 2022-02-03 13G/A 3,090,062 2,851,198 -7.73 5.50 -11.29
2021-02-02 2021-02-02 13G 3,090,062 6.20

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F KODIAK SCIENCES COM 50015M109 3,935,302 -19,301 -0.49 150,014 35.67 0.0002
2026-02-12 2025-12-31 13F KODIAK SCIENCES COM 50015M109 3,954,603 1,002,222 33.95 110,571 128.78 0.0019
2025-11-12 2025-09-30 13F KODIAK SCIENCES COM 50015M109 2,952,381 -627,061 -17.52 48,330 262.00 0.0008
2025-08-12 2025-06-30 13F KODIAK SCIENCES COM 50015M109 3,579,442 -152,437 -4.08 13,351 27.55 0.0003
2025-05-02 2025-03-31 13F KODIAK SCIENCES COM 50015M109 3,731,879 4,348 0.12 10,468 -71.78 0.0002
2025-02-07 2024-12-31 13F KODIAK SCIENCES COM 50015M109 3,727,531 -210,401 -5.34 37,089 260.85 0.0008
2024-11-13 2024-09-30 13F KODIAK SCIENCES COM 50015M109 3,937,932 91,105 2.37 10,278 13.69 0.0002
2024-08-13 2024-06-30 13F KODIAK SCIENCES COM 50015M109 3,846,827 -11,794 -0.31 9,040 -55.46 0.0002
2024-05-10 2024-03-31 13F KODIAK SCIENCES COM 50015M109 3,858,621 -174,201 -4.32 20,296 65.56 0.0005
2024-02-13 2023-12-31 13F KODIAK SCIENCES COM 50015M109 4,032,822 -438,873 -9.81 12,260 52.30 0.0003
2023-11-13 2023-09-30 13F KODIAK SCIENCES COM 50015M109 4,471,695 -35,744 -0.79 8,049 -74.12 0.0002
2023-08-11 2023-06-30 13F KODIAK SCIENCES COM 50015M109 4,507,439 91,551 2.07 31,101 13.60 0.0009
2023-05-12 2023-03-31 13F KODIAK SCIENCES COM 50015M109 4,415,888 128,079 2.99 27,379 -10.82 0.0008
2023-02-13 2022-12-31 13F KODIAK SCIENCES COM 50015M109 4,287,809 174,046 4.23 30,701 -3.58 0.0010
2022-11-14 2022-09-30 13F KODIAK SCIENCES COM 50015M109 4,113,763 -12,292 -0.30 31,841 1.01 0.0011
2022-08-12 2022-06-30 13F KODIAK SCIENCES COM 50015M109 4,126,055 690,095 20.08 31,523 18.84 0.0010
2022-05-12 2022-03-31 13F KODIAK SCIENCES COM 50015M109 3,435,960 584,762 20.51 26,526 -89.03 0.0007
2022-02-10 2021-12-31 13F KODIAK SCIENCES COM 50015M109 2,851,198 239,749 9.18 241,724 -3.56 0.0062
2021-11-09 2021-09-30 13F KODIAK SCIENCES COM 50015M109 2,611,449 2,432 0.09 250,646 3.30 0.0070
2021-08-11 2021-06-30 13F KODIAK SCIENCES COM 50015M109 2,609,017 -498,880 -16.05 242,640 -31.15 0.0068
2021-05-07 2021-03-31 13F KODIAK SCIENCES COM 50015M109 3,107,897 17,835 0.58 352,404 -22.37 0.0104
2021-02-05 2020-12-31 13F KODIAK SCIENCES COM 50015M109 3,090,062 401,517 14.93 453,961 185.17 0.0145
2020-11-06 2020-09-30 13F KODIAK SCIENCES COM 50015M109 2,688,545 -152,845 -5.38 159,189 3.52 0.0059
2020-08-14 2020-06-30 13F KODIAK SCIENCES COM 50015M109 2,841,390 263,761 10.23 153,776 25.07 0.0061
2020-05-01 2020-03-31 13F KODIAK SCIENCES COM 50015M109 2,577,629 518,392 25.17 122,953 -17.01 0.0060
2020-02-13 2019-12-31 13F KODIAK SCIENCES COM 50015M109 2,059,237 559,700 37.32 148,161 587.04 0.0057
2019-11-08 2019-09-30 13F KODIAK SCIENCES COM 50015M109 1,499,537 173,098 13.05 21,565 38.95 0.0009
2019-08-22 2019-06-30 13F/A-1 KODIAK SCIENCES COM 50015M109 1,326,439 897,126 208.97 15,520 453.50 0.0007
2019-08-13 2019-06-30 13F KODIAK SCIENCES COM 50015M109 1,326,439 897,126 15,520
2019-05-09 2019-03-31 13F KODIAK SCIENCES COM 50015M109 429,313 -12,774 -2.89 2,804 -10.67 0.0001
2019-02-08 2018-12-31 13F KODIAK SCIENCES COM 50015M109 442,087 442,087 3,139 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.